Evidence showed that targeting blood pressure below 140/90 mmHg reduced severe hypertension without increasing fetal growth restriction, and remote monitoring showed promise for postpartum management, yet long-term cardiovascular benefits require confirmation.
Abstract
INTRODUCTION/
Objectives
Chronic hypertension in pregnancy is increasingly prevalent and is associated with substantial maternal and fetal morbidity, including superimposed preeclampsia, placental abruption, fetal growth restriction, preterm birth and long-term cardiovascular disease. This review summarizes evidence on pathophysiology, risk stratification, management and outcomes in pregnancies complicated by chronic hypertension.
Methods
A systematic literature search was conducted in PubMed in September 2025 using MeSH terms related to hypertension, pregnancy, risk assessment, antihypertensive therapy and pregnancy outcomes. Studies published in English between 2000 and 2025 were included. The review followed the PRISMA 2020 guidelines and a qualitative synthesis was performed.
Results
A total of 141 studies were included. Chronic hypertension confers a 5-fold increased risk of pre-eclampsia and is associated with adverse maternal and perinatal outcomes through impaired cardiovascular adaptation, endothelial dysfunction and abnormal placentation. Evidence showed that targeting blood pressure below 140/90 mmHg reduced severe hypertension without increasing fetal growth restriction. First-trimester screening combining maternal characteristics, uterine artery doppler and angiogenic biomarkers improved pre-eclampsia prediction. Low-dose aspirin reduced risk, although effectiveness varied.
Discussion
Uncertainties remain regarding optimal blood pressure targets, aspirin efficacy in chronic hypertension, and integration of angiogenic biomarkers into routine risk stratification. The sFlt-1/PlGF ratio showed value for short-term pre-eclampsia prediction but performed poorly as a standalone predictor of adverse outcomes. Remote monitoring showed promise for postpartum management, yet long-term cardiovascular benefits require confirmation.
Conclusions
Chronic hypertension requires individualized multidisciplinary care from preconception through the postpartum period. Pregnancy acts as an early marker of future cardiovascular risk, underscoring the need for structured long-term follow-up and integration of obstetric and cardiovascular care.
Hypertensive disorders of pregnancy are increasingly recognized as early indicators of long-term maternal cardiovascular vulnerability rather than conditions limited to gestation. This study analyzed the association between hypertensive disorders of pregnancy and subsequent cardiovascular risk, with particular emphasis...
Adriana Patricia Núñez Manohatl, Jefferson Salguero-Sánchez, Alberto Macías Rodríguez et al.· IECCMEXICO· 0 citations
Background: Pregnancy in women with kidney disease is associated with an increased risk of maternal and obstetric complications, including preeclampsia, preterm delivery, and deterioration of kidney function. The magnitude of risk increases with advancing chronic kidney disease (CKD) stage and is further influenced by...
L. Garazhayeva, Meiirbek Kengessov, S. Sarsenova· Central Asian Journal of Nep...· 0 citations
Abstract Pregnancy represents a critical period during which the maternal cardiovascular system adapts to profound haemodynamic and metabolic demands. When these adaptive mechanisms are impaired, adverse pregnancy outcomes (APOs)—including hypertensive disorders of pregnancy, gestational diabetes, pre-term birth, small...
V. Giorgione, N. Parikh, D. Pedicino et al.· European Heart Journal· 1 citation
BACKGROUND
Adverse pregnancy outcomes (APOs) - including hypertensive disorders of pregnancy, preeclampsia, gestational diabetes mellitus (GDM), preterm birth, and fetal growth deviations - are emerging female-specific cardiovascular risk factors, but their association with long-term maternal atrial fibrillation (AF) r...
P. Batista, R. Huntermann, M. Montenegro et al.· European Journal of Obstetri...· 0 citations
Hypertensive disorders of pregnancy (HDP), including preeclampsia, gestational hypertension, and eclampsia, complicate up to 10% of pregnancies and are increasingly recognized as female-specific cardiovascular risk factors. However, the magnitude, timing, and hierarchy of long-term cardiovascular risk—including h...
A. Prameela, D. Raja Kuraku, N. Keshapogu et al.· European Heart Journal· 0 citations
It is demonstrated that not all severe features carry equal odds of adverse pregnancy outcome and highlight the importance of considering both the type and number of criteria when risk stratifying patients and guiding clinical management.
Hannaneh Mirmozaffari, M. Fuller, Madison Calvert et al.· American Journal of Obstetri...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.